Trial intelligence / Profile preview

Adalimumab plus physiotherapy versus placebo plus physiotherapy for sciatica

2015-000636-15Phase 3Terminated

Sponsor
Bangor University
Start
Jul 2015
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Phase 3, randomised trial in Sciatica comparing Adalimumab plus physiotherapy with Placebo saline injection plus physiotherapy (2 arms). Primary endpoint: Back pain specific disability. Started Jul 2015; status: terminated.

02

Drugs

03

Conditions

Sciatica

Beyond the preview

Go deeper on 2015-000636-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-000636-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call